Skip to main content
. Author manuscript; available in PMC: 2020 Aug 11.
Published in final edited form as: Mucosal Immunol. 2020 Feb 11;13(4):691–701. doi: 10.1038/s41385-020-0264-z

Figure 5. Bone marrow-derived macrophages (BMDMs) treated with XOI during RSV infection show decreased expression of IL-1β and CCL2.

Figure 5.

A) qPCR XO expression in BMDMs that were RSV infected. B and C) Expression and production of IL-β by BMDMs treated with or without XOI during RSV infection. D and E) CCL2 expression and production in BMDMs treated with or without XOI during RSV infection. F and G) Expression of IL-1β and CCL2 in BMDMs treated with uric acid during RSV infection. Data represent the Mean ± SE from 4 replicates per group (experimental repeats 3). * P≤0.05, ** P≤.01, *** P≤0.001.